Black Rock Inc. Allena Pharmaceuticals, Inc. Transaction History

Black Rock Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$0.02 - $0.23 $4,564 - $52,489	-228,215 Closed	0 $0
Q2 2022 Aug 12, 2022	SELL	$0.08 - $0.26 $2,456 - $7,983	-30,705 Reduced 11.86%	228,215 $44,000
Q1 2022 May 12, 2022	SELL	$0.23 - $0.65 $1,223 - $3,457	-5,319 Reduced 2.01%	258,920 $61,000
Q4 2021 Feb 10, 2022	BUY	$0.59 - $1.0 $5,203 - $8,819	8,819 Added 3.45%	264,239 $156,000
Q3 2021 Nov 09, 2021	BUY	$0.78 - $1.39 $4,534 - $8,081	5,814 Added 2.33%	255,420 $230,000

Q2 2021 Aug 11, 2021	BUY	$1.08 - $1.38 $269,574 - $344,456	249,606 New	249,606 $325,000

Ticker ALNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 122,083,000
Market Cap $9.16M
Description
Allena Pharmaceuticals, Inc., a biopharmaceutical company, discovers, develops, and commercializes oral enzyme therapeutics to treat patients with rare and severe metabolic, and kidney disorders in the United States. Its lead product candidate is ALLN-346, a novel and urate degrading enzyme for patients with hyperuricemia and gout in the setting...

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

Stay updated on Black Rock Inc. with notifications on news.